QJ ANTIINFECTIVES FOR SYSTEMIC USE
QJ05 ANTIVIRALS FOR SYSTEMIC USE
QJ05A DIRECT ACTING ANTIVIRALS
QJ05AP Antivirals for treatment of HCV infections
QJ05AP01 ribavirin
QJ05AP02 telaprevir
QJ05AP03 boceprevir
QJ05AP04 faldaprevir
QJ05AP05 simeprevir
QJ05AP06 asunaprevir
QJ05AP07 daclatasvir
QJ05AP08 sofosbuvir
QJ05AP09 dasabuvir
QJ05AP10 elbasvir
QJ05AP11 grazoprevir
QJ05AP12 coblopasvir
QJ05AP13 ravidasvir
QJ05AP51 sofosbuvir and ledipasvir
QJ05AP52 dasabuvir, ombitasvir, paritaprevir and ritonavir
QJ05AP53 ombitasvir, paritaprevir and ritonavir
QJ05AP54 elbasvir and grazoprevir
QJ05AP55 sofosbuvir and velpatasvir
QJ05AP56 sofosbuvir, velpatasvir and voxilaprevir
QJ05AP57 glecaprevir and pibrentasvir
QJ05AP58 daclatasvir, asunaprevir and beclabuvir
Last updated: 2024-01-17